SOURCE: Beardsworth


February 15, 2012 06:30 ET

Beth Butler to Lead Beardsworth Site Ambassador Program

Beardsworth's Site Ambassador Program Focuses on Stronger Clinical Site Relationships

FLEMINGTON, NJ--(Marketwire - Feb 15, 2012) - Beardsworth announces the appointment of Beth Butler, RN, as Director, Strategic Development, to lead the company's Site Ambassador Program.

"Relationships are key to supporting and expanding site involvement in clinical trials," said Ms. Butler, "and the sites are on the front line for achieving rapid, targeted patient enrollment and retention." Ms. Butler brings 12 years of clinical research experience to Beardsworth's Site Ambassador Program. The program provides strategic guidance for site identification and enables investigator involvement to enhance clinical trial success.

"Bridging the gap between identifying qualified investigators and then supporting those sites throughout the clinical trial process is an ongoing challenge for CROs and Sponsors alike," said Michael O'Brien, Beardsworth President and CEO. "We're delighted to have Beth join us in this initiative to build and sustain more effective and productive site relationships."

Ms. Butler's operational expertise is grounded in her work as a critical care nurse and as a clinical research project manager at US Oncology and ION, two of the largest Community Oncology networks. Most recently, she was a Medical Science Liaison for Allos Therapeutics covering the Southwestern and Central US.

Ms. Butler's institutional experience complements Beardsworth's Medical Affairs team, which includes staff physicians Drs. Alison Martin and Robert Malone, and will extend to OncologyOne®, the Beardsworth solution for global trials.

Ms. Butler will join Michael O'Brien at the 2012 Partnerships in Clinical Trials (March 4-7, Orlando), where he will be presenting Outsourcing Selection and Start up Process for Small Companies Going Global.

About Beardsworth Consulting Group

Beardsworth is a specialty CRO providing full-service, business solutions for complex clinical trials with particular expertise in oncology, vaccine technologies, and supportive care. Beardsworth's team of professionals averages 20+ years of experience from clinical trial design, conduct, management, safety and reporting through FDA approval. Beardsworth's OncologyOne® provides complete business and research strategies for global trials. Celebrating 25 years in business, Beardsworth is a federal CCR registrant and designated Small Business.

Contact Information